|
Device was used in treatment.The device was not returned for analysis, as it was not kept by the or team; the investigation will focus on a review of product documentation.The device history records were reviewed to confirm that the device passed all applicable in process and final inspections.Per destino steerable guiding sheath in-process and final inspection procedure: deflection test qa performs inspection as per sampling plan ansi z 1.4, gen level ii, normal, aql 0.40.Perform deflection test according to procedure.The deflection test is performed by manufacturing personnel and observed qa personnel.A fixture template is used to verify the pull force required to deflect the guiding sheath.For unidirectional destino, the deflection should be maximum 170° (nominal 180° - 10°) from the straight position of the sheath distal tip in one direction.It also verifies the length of the curve.The instructions for use (ifu) in forms user: avoid subjecting the device to unusual stresses.Handle the steerable sheath with care at all times.Before removing the steerable sheath from packaging, straighten the distal section as much as possible to avoid damage during removal.Refer to "deflecting and straightening the steerable sheath" for instructions.To ensure retention of the desired deflection positions(s), avoid contact with the deflection collar that may cause the sheath to change deflection shape.Do not deflect the sheath with dilator or with the device inserted.When in the deflection position, the steerable sheath should not be rotated while encountering resistance since that could severely damage the vessel, heart chamber, or anatomy of the patient.Based on the investigation, a capa is not required as findings did not identify a design, labeling or manufacturing non-conformity.The event will be re-evaluated if additional information becomes available.Oscor will continue to monitor this event type and risk.Oscor inc.Is submitting the above report to comply with 21 cfr part 803, the medical device reporting regulation.The report is based upon information obtained by oscor inc.Which the company may not have been able to investigate or verify prior to the date the report was required by fda.This report does not constitute an admission that the device, oscor inc., or its employees, caused or contributed to the event described in this report.Nor does this report reflect a conclusion by fda, oscor inc., or its employees, that the report constitutes an admission that the device, oscor inc., or its employees caused or contributed to the event described in this report.
|